Stay updated on Ciforadenant Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the Ciforadenant Safety and Efficacy Clinical Trial page.

Latest updates to the Ciforadenant Safety and Efficacy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include new information about the study of Ciforadenant in combination with Atezolizumab for Renal Cell Cancer, including details about the study's collaborators and the revision number. The previous detailed descriptions of the study's methodology and criteria have been removed.SummaryDifference26%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Ciforadenant Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ciforadenant Safety and Efficacy Clinical Trial page.